Cubist Systematic Strategies, LLC Immunome Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.54 - $22.11 $624,510 - $1.2 Million
-54,117 Reduced 73.59%
19,421 $234,000
Q1 2024

May 15, 2024
BUY
$11.01 - $27.34 $696,844 - $1.73 Million
63,292 Added 617.72%
73,538 $1.81 Million
Q4 2023

Feb 14, 2024
BUY
$7.3 - $10.73 $72,613 - $106,731
9,947 Added 3326.76%
10,246 $109,000
Q3 2023

Nov 14, 2023
BUY
$6.17 - $9.16 $1,844 - $2,738
299 New
299 $2,000

Others Institutions Holding IMNM

# of Institutions
121
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $133M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email